Current Affairs

FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes

(MedPage Today)-The agency announced on Friday that insulin-insulin-zjj (Merilog) as the first fast-insulin insulin product deals with adults and children with diabetes. Like his reference counterpart, insulin Asbart (Novology …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button